SV Life Sciences Fund II (SVLSFII)

SVLSF II closed in 1999 with total commitments of $280 million (plus $30 million of co-investments committed by partners and individuals affiliated with SVLS).

As at 31 December 2006, SVLSF II had invested $315 million (including re-investment) in 36 portfolio companies.

To go to individual portfolio companies websites please click on company logo.

Medical Devices AcuFocus AcuFocus: US

First investment: 2001 - Seed

Implantable contact lens.


Argonaut Technologies Argonaut Technologies: US

First investment: 1999 - Expansion - Exited

Chemistry instrumentation for accelerated synthesis of novel organic molecules. Bought by Biotage after our exit.


Cardiac Support Systems Cardiac Support Systems: US

First investment: 2000 - Seed - Exited

This was an innovation factory company.


CardioFocus CardioFocus: US

First investment: 1999 - Early Stage

Laser based ablation devices.


Cerebral Vascular Applications Cerebral Vascular Applications: US

First investment: 2000 - Seed

Minimally invasive atrial fibrillation devices.

Funded through the innovation factory


Confluent Surgical Confluent Surgical: US

First investment: 1999 - Early Stage

Biomaterials for adhesion prevention and vascular embolics.


Insulet Insulet: US

First investment SVLSF II: 2001 - Start Up
First investment SVLSF III: 2004 - Late Stage

Disposable insulin infusion devices for diabetes.


Liposonix Liposonix: US

First investment SVLSF II: 2001 - Seed
First investment SVLSF III: 2003 - Seed

Focused ultrasound alternative to liposuction.

Funded through the innovation factory.


Back to Top


web design - xenex-media.com
Legal